Product Information
IMIPRAMINE HCL 25 MG TABLET is a generic product labeled by Oxford Pharmaceuticals, LLC, priced at $0.0841 per EA under NDC 69584042690. Its NADAC has been published 197 times since Sep 21, 2022.
Strength
25 mg/1
Manufacturer
Oxford Pharmaceuticals, LLCNDC
69584042690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040751On Market Since
8/1/2020
Pharmacological Classes
Price Statistics
The NADAC for IMIPRAMINE HCL 25 MG TABLET has been published 197 times since Sep 21, 2022, and over the history we have for it it has declined 12.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0841 per EA |
|---|---|
| All-time high | $0.1055 (Dec 13, 2023) |
| All-time low | $0.0746 (Nov 20, 2024) |
| 52-week high | $0.0909 |
| 52-week low | $0.0806 |
| Median price | $0.0909 |
| Average price | $0.0907 |
| Largest weekly change | +27.4% (Mar 20, 2024) |
| Weeks tracked | 197 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMIPRAMINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IMIPRAMINE HCL 25 MG TABLET, manufactured by Oxford Pharmaceuticals, LLC, is $0.0841 per EA (NDC 69584042690), effective Jun 24, 2026.
How has the price of IMIPRAMINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for IMIPRAMINE HCL 25 MG TABLET has declined 12.6%. It has been tracked across 197 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for IMIPRAMINE HCL 25 MG TABLET?
Since Sep 21, 2022, the NADAC for IMIPRAMINE HCL 25 MG TABLET has ranged from a low of $0.0746 (Nov 20, 2024) to a high of $0.1055 (Dec 13, 2023), with a median of $0.0909 per EA.
Are there cheaper alternatives to IMIPRAMINE HCL 25 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as IMIPRAMINE HCL 25 MG TABLET, but none are currently priced below it.
Who manufactures IMIPRAMINE HCL 25 MG TABLET?
IMIPRAMINE HCL 25 MG TABLET (NDC 69584042690) is labeled by Oxford Pharmaceuticals, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification